Consolidated was Incannex Healthcare’s largest segment in fiscal 2021, bringing in $1.90M of $3.80M (50%).
| Segments [axis] | FY 2021 |
|---|---|
| Consolidated | $1.90M |
| Cannabinoid Products | $1.90M |
| Total | $3.80M |
Incannex Healthcare brought in $3.80M from its two segments in fiscal 2021, the year ended June 30, 2021. Consolidated was the largest at $1.90M (50.0%), ahead of Cannabinoid Products at $1.90M (50.0%).
Incannex Healthcare (IXHL) reports its revenue by segments [axis]. In fiscal 2021, Consolidated was its largest segment, bringing in $1.90M (50.0% of the total), followed by Cannabinoid Products at $1.90M (50.0%).
Consolidated was Incannex Healthcare's largest segment in fiscal 2021, bringing in $1.90M, or 50.0% of the $3.80M total across its two segments.
Every figure comes from Incannex Healthcare's annual financial filings, as reported. Each line keeps the name Incannex Healthcare gives it, and years follow its fiscal calendar.
Incannex Healthcare's revenue by segments [axis] goes back to fiscal 2021, with figures through fiscal 2021. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.